All individual trials at Neurotech Pharmaceuticals

An AllTrials project

All individual trials at Neurotech Pharmaceuticals

5 out of 6

83.3%

$48,740,197

$0

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
overdue	Neurotech Pharmaceuticals	NCT01949324	A Phase 2 Multicenter Randomized Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel) [pACT]	2017-04-14	1814
reported-late	Neurotech Pharmaceuticals	NCT01530659	Photoreceptor Structure in A Phase 2 Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants With Retinitis Pigmentosa Using Rates of Change in Cone Spacing and Density [pACT]	2019-07-01	660
reported-late	Neurotech Pharmaceuticals	NCT03071965	Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)	2021-05-11	1034
reported-late	Neurotech Pharmaceuticals	NCT03319849	A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2	2022-08-31	328
reported-late	Neurotech Pharmaceuticals	NCT03316300	A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2	2022-08-31	328
reported-late	Neurotech Pharmaceuticals	NCT04729972	Phase II, Multicenter, Open-label Safety Study of Bilateral NT-501 in Participants With Macular Telangiectasia Type 2	2022-12-08	229
ongoing	Neurotech Pharmaceuticals	NCT06397131	A Multicenter Study to Determine the Safety and Efficacy of NT-501 Utilizing the Medica Membrane in Macular Telangiectasia Type 2	2026-04-27

Download this data